Umeå University's logo

umu.sePublications
Change search
Link to record
Permanent link

Direct link
Alternative names
Publications (10 of 121) Show all publications
Forfang, E., Larsen, K. T., Salman, R.-S. A., Bell, S. M., Wester, P., Berge, E., . . . Rønning, O. M. (2023). Antithrombotic treatment after intracerebral hemorrhage: surveys among stroke physicians in Scandinavia and the United Kingdom. Health Science Reports, 6(1), Article ID e1059.
Open this publication in new window or tab >>Antithrombotic treatment after intracerebral hemorrhage: surveys among stroke physicians in Scandinavia and the United Kingdom
Show others...
2023 (English)In: Health Science Reports, E-ISSN 2398-8835, Vol. 6, no 1, article id e1059Article in journal (Refereed) Published
Abstract [en]

Background and Aims: It is unclear whether patients with previous intracerebral hemorrhage (ICH) should receive antithrombotic treatment to prevent ischemic events. We assessed stroke physicians' opinions about this, and their views on randomizing patients in trials assessing this question.

Methods: We conducted three web-based surveys among stroke physicians in Scandinavia and the United Kingdom.

Results: Eighty-nine of 205 stroke physicians (43%) responded to the Scandinavian survey, 161 of 180 (89%) to the UK antiplatelet survey, and 153 of 289 (53%) to the UK anticoagulant survey. In Scandinavia, 19 (21%) stroke physicians were uncertain about antiplatelet treatment after ICH for ischemic stroke or transient ischemic attack (TIA) and 21 (24%) for prior myocardial infarction. In the United Kingdom, 116 (77%) were uncertain for ischemic stroke or TIA and 115 (717%) for ischemic heart disease. In Scandinavia, 32 (36%) were uncertain about anticoagulant treatment after ICH for atrial fibrillation, and 26 (29%) for recurrent deep vein thrombosis or pulmonary embolism. In the United Kingdom, 145 (95%) were uncertain about anticoagulants after ICH in at least some cases. In both regions combined, 191 of 250 (76%) would consider randomizing ICH survivors in a trial of starting versus avoiding antiplatelets, and 176 of 242 (73%) in a trial of starting versus avoiding anticoagulants.

Conclusion: Considerable proportions of stroke physicians in Scandinavia and the United Kingdom were uncertain about antithrombotic treatment after ICH. A clear majority would consider randomizing patients in trials assessing this question. These findings support the need for such trials.

Place, publisher, year, edition, pages
John Wiley & Sons, 2023
Keywords
antithrombotic treatment, intracerebral hemorrhage, ischemic events, secondary prevention, stroke
National Category
Neurology Cardiac and Cardiovascular Systems
Identifiers
urn:nbn:se:umu:diva-204485 (URN)10.1002/hsr2.1059 (DOI)000916082600001 ()36698713 (PubMedID)2-s2.0-85147018912 (Scopus ID)
Available from: 2023-02-17 Created: 2023-02-17 Last updated: 2023-03-24Bibliographically approved
Nyman, E., Liv, P., Wester, P., Näslund, U. & Grönlund, C. (2023). Carotid wall echogenicity at baseline associates with accelerated vascular aging in a middle-aged population. The International Journal of Cardiovascular Imaging, 39(3), 575-583
Open this publication in new window or tab >>Carotid wall echogenicity at baseline associates with accelerated vascular aging in a middle-aged population
Show others...
2023 (English)In: The International Journal of Cardiovascular Imaging, ISSN 1569-5794, E-ISSN 1875-8312, Vol. 39, no 3, p. 575-583Article in journal (Refereed) Published
Abstract [en]

Ultrasonic echolucent carotid intima-media (IM) complex and accelerated progression of carotid intima mediathickness (cIMT) have both separately been shown to predict future cardiovascular events. The aim of this studywas to evaluate if the echogenicity of the IM-complex is associated with the 3-year progression of cIMT. B-modeultrasound images captured at baseline and 3-year follow-up in the ‘Visualization of asymptomatic atherosclerotic disease for optimum cardiovascular prevention’ (VIPVIZA) trial were included (n: 3154). The bilateral mean cIMT and IM-echogenicity by greyscale median (GSM) were measured in the common carotid artery. Associations between IM-GSM at baseline and the 3-year cIMT progression were investigated using linear regression models for the whole population and stratified by sex, age and VIPVIZA study group (intervention versus control). In addition, adjusted analyses for confounding factors were performed. Unadjusted analysis showed that decreased IM-GSM at baseline was associated with increased progression of cIMT (p < 0.001). Stratified by age, the association was significant among 40 (p < 0.001) and 60 years old (p < 0.001). The association was statistically significant in both sexes and on comparison of VIPVIZA study subgroups. Adjustments for confounding factors did not alter the estimated relationship between IM-GSM and cIMT progression. Echolucent carotid intima media at baseline associates with increased 3-year cIMT progression among an asymptomatic, middle-aged population. Echogenicity of the intima media may identify individuals at risk for accelerated vascular aging.

Place, publisher, year, edition, pages
Springer Science+Business Media B.V., 2023
Keywords
Asymptomatic, Atherosclerosis, Carotid intima media, Echogenicity, Ultrasound
National Category
Cardiac and Cardiovascular Systems
Identifiers
urn:nbn:se:umu:diva-204476 (URN)10.1007/s10554-022-02760-3 (DOI)000919023200002 ()36680684 (PubMedID)2-s2.0-85146659539 (Scopus ID)
Funder
Region Västerbotten, ALFVLL-298001Region Västerbotten, ALFVLL643391Swedish Research Council, 521-2013-2708Swedish Research Council, 2016−01891Swedish Heart Lung Foundation, 20150369Swedish Heart Lung Foundation, 20170481Swedish Society of MedicineVisare Norr
Available from: 2023-02-17 Created: 2023-02-17 Last updated: 2023-09-05Bibliographically approved
Jonsson, M., Hammar, K., Lindberg, M., Lundström, A., Franko, M. A., Laska, A.-C., . . . Mani, K. (2023). Editor's Choice – Nationwide Outcome Analysis of Primary Carotid Endarterectomy in Symptomatic Patients Depending on Closure Technique and Patch Type. European Journal of Vascular and Endovascular Surgery, 65(4), 467-473
Open this publication in new window or tab >>Editor's Choice – Nationwide Outcome Analysis of Primary Carotid Endarterectomy in Symptomatic Patients Depending on Closure Technique and Patch Type
Show others...
2023 (English)In: European Journal of Vascular and Endovascular Surgery, ISSN 1078-5884, E-ISSN 1532-2165, Vol. 65, no 4, p. 467-473Article in journal (Refereed) Published
Abstract [en]

Objective: Current European guidelines recommend both eversion carotid endarterectomy (CEA) and conventional CEA with routine patch closure, rather than routine primary closure. Polyester and polytetrafluoroethylene (PTFE) have been used as patch material for a long time. More recently, bovine pericardium has been used; however, there are few studies comparing long term results between bovine pericardium and other patch types. The aim of this study was to investigate the short and long term results after CEA depending on surgical technique and patch material.

Methods: A registry based study on all primary CEAs (n = 9 205) performed for symptomatic carotid artery stenosis in Sweden from July 2008 to December 2019, cross linked with data from the Swedish stroke registry, Riksstroke, and chart review for evaluation of any events occurring during follow up. The primary endpoint was ipsilateral stroke < 30 days. Secondary endpoints included re-operations due to neck haematoma and < 30 day ipsilateral stroke, > 30 day ipsilateral stroke, all stroke > 30 days, and all cause mortality.

Results: 2 495 patients underwent eversion CEA and 6 710 conventional CEA for symptomatic carotid stenosis. The most commonly used patch material was Dacron (n = 3 921), followed by PTFE (n = 588) and bovine pericardium (n = 413). A total of 1 788 patients underwent conventional CEA with primary closure. Two hundred and seventy-three patients (3.0%) had a stroke < 30 days. Primary closure was associated with an increased risk of ipsilateral stroke and stroke or death <30 days: odds ratio 1.7 (95% confidence interval [CI] 1.2 – 2.4, p = .002); and 1.5 (95% CI 1.2 – 2.0), respectively. During follow up (median 4.2 years), 592 patients had any form of stroke and 1 492 died. There was no significant difference in long term risk of ipsilateral stroke, all stroke, or death depending on surgical technique or patch material.

Conclusion: There was an increased risk of ipsilateral stroke < 30 days in patients operated on with primary closure compared with eversion CEA and patch angioplasty. There was no difference between primary closure, different patch types, or eversion after the peri-operative phase.

Place, publisher, year, edition, pages
Elsevier, 2023
Keywords
Bovine pericardium, Carotid endarterectomy, Carotid stenosis, Direct suture, Eversion, Patch
National Category
Surgery
Identifiers
urn:nbn:se:umu:diva-212429 (URN)10.1016/j.ejvs.2022.12.033 (DOI)000994588800001 ()36603661 (PubMedID)2-s2.0-85148466093 (Scopus ID)
Available from: 2023-07-27 Created: 2023-07-27 Last updated: 2023-07-27Bibliographically approved
Ullberg, T., Von Euler, M., Wester, P., Arnberg, F., Norrving, B., Andersson, T. & Wassélius, J. (2023). Endovascular thrombectomy for anterior circulation stroke beyond 6 hours of onset in Sweden 2015 to 2020: Rates and outcomes in a nationwide register-based study. Journal of NeuroInterventional Surgery, 15(4), 330-335
Open this publication in new window or tab >>Endovascular thrombectomy for anterior circulation stroke beyond 6 hours of onset in Sweden 2015 to 2020: Rates and outcomes in a nationwide register-based study
Show others...
2023 (English)In: Journal of NeuroInterventional Surgery, ISSN 1759-8478, Vol. 15, no 4, p. 330-335Article in journal (Refereed) Published
Abstract [en]

Background: Endovascular thrombectomy (EVT) for ischemic stroke (IS) beyond 6 hours has been proven effective in randomized controlled trials. We present data on implementation and outcomes for EVT beyond 6 hours in Sweden.

Methods: We included all cases of anterior circulation IS caused by occlusion of the intracranial carotid artery, and the M1 or M2 segment of the middle cerebral artery, registered in two nationwide quality registers for stroke in 2015-2020. Three groups were defined from onset-to-groin-puncture (OTG) time: early window (<6 hours), late window (6-24 hours) known onset, late window last seen well (LSW). Favorable outcome (modified Rankin Scale (mRS) 0-2) and all-cause mortality at 90 days were the main outcomes, and symptomatic intracerebral hemorrhage (sICH) was the safety outcome.

Results: Late window EVT increased from 0.3% of all IS in 2015 to 1.8% in 2020, and from 17.4% of all anterior circulation EVTs in 2015 to 32.9% in 2020. Of 2199 patients, 76.9% (n=1690) were early window EVTs and 23.1% late window EVTs (n=509; 141 known onset, 368 LSW). Median age was 73 years, and 46.2% were female, with no differences between groups. Favorable outcome did not differ between groups (early window 42.4%, late window known onset 38.9%, late window LSW 37.3% (p=0.737)) and remained similar when adjusted for baseline differences. sICH rates did not differ (early window 4.0%, late window known onset 2.1%, late window LSW 4.9% (p=0.413)).

Conclusion: Late window EVTs have increased substantially over time, and currently account for one third of anterior circulation treatments. Early and late window patients had similar outcomes.

Place, publisher, year, edition, pages
BMJ Publishing Group Ltd, 2023
Keywords
CT perfusion, Stroke, Thrombectomy, Thrombolysis
National Category
Neurology
Identifiers
urn:nbn:se:umu:diva-193816 (URN)10.1136/neurintsurg-2022-018670 (DOI)000771049800001 ()35301261 (PubMedID)2-s2.0-85150311660 (Scopus ID)
Available from: 2022-05-06 Created: 2022-05-06 Last updated: 2023-08-10Bibliographically approved
Rohlén, R., Jiang, B., Nyman, E., Wester, P., Näslund, U. & Grönlund, C. (2023). Interframe Echo Intensity Variation of Subregions and Whole Plaque in Two-Dimensional Carotid Ultrasonography: Simulations and in Vivo Observations. Journal of ultrasound in medicine, 42(5), 1033-1046
Open this publication in new window or tab >>Interframe Echo Intensity Variation of Subregions and Whole Plaque in Two-Dimensional Carotid Ultrasonography: Simulations and in Vivo Observations
Show others...
2023 (English)In: Journal of ultrasound in medicine, ISSN 0278-4297, E-ISSN 1550-9613, Vol. 42, no 5, p. 1033-1046Article in journal (Refereed) Published
Abstract [en]

Objectives: The risk of cardiovascular disease is associated with the echo intensity of carotid plaques in ultrasound images and their cardiac cycle-induced intensity variations. In this study, we aimed to 1) explore the underlying origin of echo intensity variations by using simulations and 2) evaluate the association between the two-dimensional (2D) spatial distribution of these echo intensity variations and plaque vulnerability.

Methods: First, we analyzed how out-of-plane motion and compression of simulated scattering spheres of different sizes affect the ultrasound echo intensity. Next, we propose a method to analyze the features of the 2D spatial distribution of interframe plaque echo intensity in carotid ultrasound image sequences and explore their associations with plaque vulnerability in experimental data.

Results: The simulations showed that the magnitude of echo intensity changes was similar for both the out-of-plane motion and compression, but for scattering objects smaller than 1 mm radius, the out-of-plane motion dominated. In experimental data, maps of the 2D spatial distribution of the echo intensity variations had a low correlation with standard B-mode echo intensity distribution, indicating complementary information on plaque tissue composition. In addition, we found the existence of ∼1 mm diameter subregions with pronounced echo intensity variations associated with plaque vulnerability.

Conclusions: The results indicate that out-of-plane motion contributes to intra-plaque regions of high echo intensity variation. The 2D echo intensity variation maps may provide complementary information for assessing plaque composition and vulnerability. Further studies are needed to verify this method's role in identifying vulnerable plaques and predicting cardiovascular disease risk.

Place, publisher, year, edition, pages
John Wiley & Sons, 2023
National Category
Cardiac and Cardiovascular Systems Medical Engineering
Identifiers
urn:nbn:se:umu:diva-200460 (URN)10.1002/jum.16114 (DOI)000870331800001 ()36264181 (PubMedID)2-s2.0-85140218004 (Scopus ID)
Funder
Swedish Research Council, 2015-04461Västerbotten County Council, VLL-581211
Available from: 2022-10-20 Created: 2022-10-20 Last updated: 2023-07-13Bibliographically approved
Engdahl, J., Straat, K., Isaksson, E., Rooth, E., Svennberg, E., Norrving, B., . . . Wester, P. (2023). Multicentre, national, investigator-initiated, randomised, parallel-group, register-based superiority trial to compare extended ECG monitoring versus standard ECG monitoring in elderly patients with ischaemic stroke or transient ischaemic attack and the effect on stroke, death and intracerebral bleeding: the AF SPICE protocol. BMJ Open, 13(11), Article ID e073470.
Open this publication in new window or tab >>Multicentre, national, investigator-initiated, randomised, parallel-group, register-based superiority trial to compare extended ECG monitoring versus standard ECG monitoring in elderly patients with ischaemic stroke or transient ischaemic attack and the effect on stroke, death and intracerebral bleeding: the AF SPICE protocol
Show others...
2023 (English)In: BMJ Open, E-ISSN 2044-6055, Vol. 13, no 11, article id e073470Article in journal (Refereed) Published
Abstract [en]

Introduction: Atrial fibrillation (AF) is a major risk factor for ischaemic stroke and transient ischaemic attack (TIA), and AF detection can be challenged by asymptomatic and paroxysmal presentation. Long-term ECG monitoring after ischaemic stroke or TIA is recommended by all major societies in cardiology and cerebrovascular medicine as a secondary prophylactic measure. However, data on stroke reduction are lacking, and the recommendations show significant diversity.

Methods and analysis: AF SPICE is a multicentre, national, investigator-initiated, randomised, parallel-group, register-based trial comparing extended ECG monitoring versus standard ECG monitoring in patients admitted with ischaemic stroke or TIA, with a composite endpoint of stroke, all-cause-mortality and intracerebral bleeding. Patients aged ≥70 years without previous AF will be randomised 1:1 to control (standard ECG monitoring) or intervention (extended ECG monitoring). In the control arm, patients will undergo 48±24 hours (ie, a range of 24-72 hours) of continuous ECG monitoring according to national recommendations. In the intervention arm, patients will undergo 14+14 days of continuous ECG monitoring 3 months apart using an ECG patch device, which will provide an easy-accessed, well-tolerated 14-day continuous ECG recording. All ECG patch recordings will be read in a core facility. In cases of AF detection, oral anticoagulation will be recommended if not contraindicated. A pilot phase has been concluded in 2022, which will transcend into the main trial during 2023-2026, including approximately 30 stroke units. The sample size was calculated to be 3262 patients. The primary outcome will be collected from register data during a 36-month follow-up.

Ethics and dissemination: Ethical approval has been provided by the Swedish Ethical Review Authority, reference 2021-02770. The trial will be conducted according to the ethical principles of the Declaration of Helsinki and national regulatory standards. Positive results from the study have the potential for rapid dissemination in clinical practice.

Trial registration number: NCT05134454.

Place, publisher, year, edition, pages
BMJ Publishing Group Ltd, 2023
Keywords
Cardiology, Stroke, Thromboembolism
National Category
Cardiac and Cardiovascular Systems
Identifiers
urn:nbn:se:umu:diva-217542 (URN)10.1136/bmjopen-2023-073470 (DOI)37996238 (PubMedID)2-s2.0-85177747244 (Scopus ID)
Funder
Swedish Research CouncilSwedish Heart Lung FoundationThe Swedish Stroke AssociationRegion Stockholm
Available from: 2023-12-13 Created: 2023-12-13 Last updated: 2023-12-13Bibliographically approved
Bengtsson, A., Nyman, E., Grönlund, C., Wester, P., Näslund, U., Fhärm, E. & Norberg, M. (2023). Multi-view carotid ultrasound is stronger associated with cardiovascular risk factors than presence of plaque or single carotid intima media thickness measurements in subclinical atherosclerosis. The International Journal of Cardiovascular Imaging, 39(8), 1461-1471
Open this publication in new window or tab >>Multi-view carotid ultrasound is stronger associated with cardiovascular risk factors than presence of plaque or single carotid intima media thickness measurements in subclinical atherosclerosis
Show others...
2023 (English)In: The International Journal of Cardiovascular Imaging, ISSN 1569-5794, E-ISSN 1875-8312, Vol. 39, no 8, p. 1461-1471Article in journal (Refereed) Published
Abstract [en]

We aimed to explore the prevalence of atherosclerosis by using multi-view ultrasound examination of the carotid arteries and its association with clinical risk factors in a middle-aged population at low to intermediate risk of cardiovascular disease (CVD). Carotid vascular ultrasound was performed in 3532 participants in the VIPVIZA trial. Mean and maximal carotid intima media thickness (cIMT) at prespecified angles and plaque presence were examined on the left and right side. Associations between CVD risk factors and ultrasound variables were quantified by partial least squares (PLS) regression. A combined ultrasound variable was computed using weights of the first PLS component. Associations between CVD risk factors and the combined multi-view ultrasound variable, single cIMT and plaque measurements, respectively, were determined using linear regression modelling. The participants’ mean age was 55.7 years and 52.9% were women. Plaque prevalence was 51.1% in men and 39.0% in women. cIMT was higher in men than in women and in the left compared with the right carotid artery. The strongest association of CVD risk factors was observed with the combined multi-view ultrasound variable (R2 = 24%), compared with single cIMT variables (R2 = 14–18%) and plaque presence (R2 = 15%). The pattern was similar in both sexes. The association with CVD risk factors and the combined ultrasound variable was stronger in 40-year olds (R2 = 22%) compared with 50- or 60-year olds (R = 12%). CVD risk factors are stronger associated with a combined ultrasound variable than plaque presence or single cIMT measures suggesting that carotid multi-view ultrasonography better captures the focality of early atherosclerosis. Clinical Trial Registration: ClinicalTrials.gov, number NCT01849575. May 8, 2013.

Place, publisher, year, edition, pages
Springer Nature, 2023
Keywords
Atherosclerosis, Cardiovascular disease, Carotid intima media thickness, Carotid plaque, Carotid ultrasound
National Category
Cardiac and Cardiovascular Systems
Identifiers
urn:nbn:se:umu:diva-209575 (URN)10.1007/s10554-023-02868-0 (DOI)000998250600001 ()37249653 (PubMedID)2-s2.0-85160655052 (Scopus ID)
Funder
Visare NorrNorrbotten County CouncilUmeå UniversityThe Swedish Medical Association, SLS-405351The Swedish Medical Association, SLS-503111Swedish Research Council, 521-2013-2708
Available from: 2023-06-12 Created: 2023-06-12 Last updated: 2023-09-20Bibliographically approved
Ennab Vogel, N., Wester, P., Andersson Granberg, T. & Levin, L.-Å. (2023). Optimized density and locations of stroke centers for improved cost effectiveness of mechanical thrombectomy in patients with acute ischemic stroke. Journal of NeuroInterventional Surgery, Article ID jnis-2023-020299.
Open this publication in new window or tab >>Optimized density and locations of stroke centers for improved cost effectiveness of mechanical thrombectomy in patients with acute ischemic stroke
2023 (English)In: Journal of NeuroInterventional Surgery, ISSN 1759-8478, article id jnis-2023-020299Article in journal (Refereed) Epub ahead of print
Abstract [en]

Background: Despite the proven cost effectiveness of mechanical thrombectomy (MT) in patients with acute ischemic stroke (AIS) due to large vessel occlusion, treatment within 6 hours from symptom onset remains inaccessible for many patients. We aimed to find the optimal number and location of treatment facilities with respect to the cost effectiveness of MT in patients with AIS, first by the most cost effective implementation of comprehensive stroke centers (CSCs), and second by the most cost effective addition of complementary thrombectomy capable stroke centers (TSCs).

Methods: This study was based on nationwide observational data comprising 18 793 patients with suspected AIS potentially eligible for treatment with MT. The most cost effective solutions were attained by solving the p median facility location-allocation problem with the objective function of maximizing the incremental net monetary benefit (INMB) of MT compared with no MT in patients with AIS. Deterministic sensitivity analysis (DSA) was used as the basis of the results analysis.

Results: The implementation strategy with seven CSCs produced the highest annual INMB per patient of all possible solutions in the base case scenario. The most cost effective implementation strategy of the extended scenario comprised seven CSCs and four TSCs. DSA revealed sensitivity to variability in MT rate and the maximum willingness to pay per quality adjusted life year gained.

Conclusion: The combination of optimization modeling and cost effectiveness analysis provides a powerful tool for configuring the extent and locations of CSCs (and TSCs). The most cost effective implementation of CSCs in Sweden entails 24/7 MT services at all seven university hospitals.

Place, publisher, year, edition, pages
BMJ Publishing Group Ltd, 2023
Keywords
economics, intervention, stroke, thrombectomy, thrombolysis
National Category
Health Care Service and Management, Health Policy and Services and Health Economy
Identifiers
urn:nbn:se:umu:diva-209175 (URN)10.1136/jnis-2023-020299 (DOI)000981480100001 ()37072170 (PubMedID)2-s2.0-85160234118 (Scopus ID)
Funder
Linköpings universitetUmeå UniversitySwedish Heart Lung Foundation
Available from: 2023-06-22 Created: 2023-06-22 Last updated: 2023-06-22
Nyman, E., Grönlund, C., Vanoli, D., Liv, P., Norberg, M., Bengtsson, A., . . . Näslund, U. (2023). Reduced progression of carotid intima media thickness by personalised pictorial presentation of subclinical atherosclerosis in VIPVIZA: A randomised controlled trial. Clinical Physiology and Functional Imaging, 43(4), 232-241
Open this publication in new window or tab >>Reduced progression of carotid intima media thickness by personalised pictorial presentation of subclinical atherosclerosis in VIPVIZA: A randomised controlled trial
Show others...
2023 (English)In: Clinical Physiology and Functional Imaging, ISSN 1475-0961, E-ISSN 1475-097X, Vol. 43, no 4, p. 232-241Article in journal (Refereed) Published
Abstract [en]

Objectives: Reduced progression of atherosclerosis can decrease the risk of cardiovascular disease (CVD). This study aimed at evaluating the effect of a pictorial intervention showing atherosclerotic severity on the progression of carotid atherosclerosis.

Methods: A prospective randomised open-label blinded end-point trial with participants aged 40–60 years enroled from a routine CVD prevention programme. The intervention group (n: 1575) and their treating physicians received an image based presentation of subclinical atherosclerotic severity measured by carotid ultrasound. The control group (n: 1579) did not receive any information about ultrasound results. Carotid ultrasound at baseline and at 3-year follow-up contained plaque detection and measurements of carotid intima media thickness (cIMT). The left, right and bilateral-mean-cIMT, plaque prevalence and total plaque area (TPA) at 3-year follow-up were compared between groups. Significance level was set to p = 0.01 to adjust for multiple comparisons.

Results: The intervention group revealed reduced cIMT progression in the left-mean-cIMT of −0.011 mm (p = 0.001) compared with the control group. The intervention effect on cIMT progression was most prominent in individuals with increased cIMT and plaque prevalence at baseline (−0.021 mm, p = 0.005). There were no differences in progression between groups for the right-and bilateral-mean-cIMT (−0.005 mm, p = 0.223 and −0.005 mm, p = 0.036, respectively), nor any differences between groups for plaque prevalence or TPA (odds ratio 0.88, p = 0.09 and 0.89, p = 0.21, respectively).

Conclusion: Pictorial presentation of subclinical atherosclerotic severity sent to both the individual and their treating physician resulted in significantly reduced left cIMT progression. Pictorial presentation has the potential to increase adherence in CVD prevention.

Place, publisher, year, edition, pages
John Wiley & Sons, 2023
Keywords
adherence, intervention, prevention, randomised controlled trial, ultrasound imaging
National Category
Cardiac and Cardiovascular Systems Physiology
Identifiers
urn:nbn:se:umu:diva-204766 (URN)10.1111/cpf.12811 (DOI)000921350300001 ()36642849 (PubMedID)2-s2.0-85147282676 (Scopus ID)
Funder
Visare NorrSwedish Society of MedicineSwedish Heart Lung Foundation, 20150369Swedish Heart Lung Foundation, 20170481Swedish Research Council, 521‐2013‐2708Swedish Research Council, 2016‐01891Swedish Research Council, 2017‐02246Region Västerbotten, ALFVLL‐298001Region Västerbotten, ALFVLL643391
Available from: 2023-02-20 Created: 2023-02-20 Last updated: 2023-07-14Bibliographically approved
Nordanstig, A., Gu, T., Henze, A., Wester, P., Fox, A. J. & Johansson, E. (2023). Risk of stroke recurrence after intravenous thrombolysis in patients with symptomatic carotid stenosis. Canadian Journal of Neurological Sciences
Open this publication in new window or tab >>Risk of stroke recurrence after intravenous thrombolysis in patients with symptomatic carotid stenosis
Show others...
2023 (English)In: Canadian Journal of Neurological Sciences, ISSN 0317-1671Article in journal (Refereed) Accepted
Abstract [en]

Objective: To assess if intravenous thrombolysis (IVT) affects the risk of recurrent preoperative cerebrovascular events before carotid surgery or stenting in patients with symptomatic ≥ 50% carotid stenosis.

Methods: Three cohorts of symptomatic ≥ 50% carotid stenosis patients were merged. To make the control group relevant, we excluded patients not presenting with stroke on the day of symptom onset. The risk of preoperative cerebrovascular events up to 30 days were compared between the IVT-treated and non-IVT-treated.

Results: 316 patients were included, 64 (20%) treated with IVT. Those treated with IVT had similar risk of recurrent ipsilateral ischemic stroke or retinal artery occlusion (12% at day 7, 12% at day 30) as those not treated (9% at day 7, 15% at day 30; adjusted HR 0.9, 95%CI 0.4-2.2). There was a tendency (p=0.09) towards time-dependency in the data where the recurrence risk was higher in IVT treated at day 0 (6% in IVT-treated, 1% in non-IVT-treated, OR 5.5, 95%CI 1.2-25.4, p=0.03). This was not significant when adjusting for co-factors (adjusted OR 4.4, 95%CI 0.9-21.8, p=0.07) and was offset by a later risk decrease, with no remaining risk difference between IVT-treated and non-IVT treated at day 7.

Conclusions: IVT treatment does not seem to affect the risk of recurrent ipsilateral ischemic stroke in patients with symptomatic ≥ 50% carotid stenosis: The risk is high in both IVT-treated and non-IVT-treated. However, there might be a risk increase on the day of IVT treatment that is offset by a risk decrease during the first week.

Place, publisher, year, edition, pages
Cambridge University Press, 2023
Keywords
Carotid stenosis, Intravenous thrombolysis, Risk, Stroke
National Category
Neurology
Identifiers
urn:nbn:se:umu:diva-214694 (URN)10.1017/cjn.2023.284 (DOI)2-s2.0-85171265322 (Scopus ID)
Funder
Knut and Alice Wallenberg FoundationRegion VästerbottenSwedish Heart Lung FoundationThe Swedish Medical Association
Available from: 2023-09-27 Created: 2023-09-27 Last updated: 2023-09-27
Organisations
Identifiers
ORCID iD: ORCID iD iconorcid.org/0000-0001-8522-1707

Search in DiVA

Show all publications